184 related articles for article (PubMed ID: 31454556)
1. Quantitative proteomic and phosphoproteomic studies reveal novel 5-fluorouracil resistant targets in hepatocellular carcinoma.
Liu Z; Wang Y; Yao Y; Fang Z; Miao QR; Ye M
J Proteomics; 2019 Sep; 208():103501. PubMed ID: 31454556
[TBL] [Abstract][Full Text] [Related]
2. Comparative proteomic analysis of protein methylation provides insight into the resistance of hepatocellular carcinoma to 5-fluorouracil.
Liu Z; Wang Q; Mao J; Wang K; Fang Z; Miao QR; Ye M
J Proteomics; 2020 May; 219():103738. PubMed ID: 32198070
[TBL] [Abstract][Full Text] [Related]
3. Characterization and resistance mechanisms of a 5-fluorouracil- resistant hepatocellular carcinoma cell line.
Gu W; Fang FF; Li B; Cheng BB; Ling CQ
Asian Pac J Cancer Prev; 2012; 13(9):4807-14. PubMed ID: 23167424
[TBL] [Abstract][Full Text] [Related]
4. MEL-pep, an analog of melittin, disrupts cell membranes and reverses 5-fluorouracil resistance in human hepatocellular carcinoma cells.
Ke M; Dong J; Wang Y; Zhang J; Zhang M; Wu Z; Lv Y; Wu R
Int J Biochem Cell Biol; 2018 Aug; 101():39-48. PubMed ID: 29800725
[TBL] [Abstract][Full Text] [Related]
5. TFPI-2 downregulates multidrug resistance protein in 5-FU-resistant human hepatocellular carcinoma BEL-7402/5-FU cells.
Lu F; Hou YQ; Song Y; Yuan ZJ
Anat Rec (Hoboken); 2013 Jan; 296(1):56-63. PubMed ID: 23125179
[TBL] [Abstract][Full Text] [Related]
6. MiR-27a modulates the MDR1/P-glycoprotein expression by inhibiting FZD7/β-catenin pathway in hepatocellular carcinoma cells.
Chen Z; Ma T; Huang C; Zhang L; Lv X; Xu T; Hu T; Li J
Cell Signal; 2013 Dec; 25(12):2693-701. PubMed ID: 24018051
[TBL] [Abstract][Full Text] [Related]
7. Proteomic Analysis Reveals that EPHX1 Contributes to 5-Fluorouracil Resistance in a Human Hepatocellular Carcinoma Cell Line.
Sun R; Dong C; Li R; Chu H; Liu J; Hao D; Zhang L; Zhao B; Wang L; Zhang Y
Proteomics Clin Appl; 2020 Jul; 14(4):e1900080. PubMed ID: 32067389
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of 5-fluorouracil required resistance in human hepatocellular carcinoma cell line Bel(7402).
Jin J; Huang M; Wei HL; Liu GT
World J Gastroenterol; 2002 Dec; 8(6):1029-34. PubMed ID: 12439919
[TBL] [Abstract][Full Text] [Related]
9. Proteomic-based analysis for identification of proteins involved in 5-fluorouracil resistance in hepatocellular carcinoma.
Tan Y; Qin S; Hou X; Qian X; Xia J; Li Y; Wang R; Chen C; Yang Q; Miele L; Wu Q; Wang Z
Curr Pharm Des; 2014; 20(1):81-7. PubMed ID: 23530500
[TBL] [Abstract][Full Text] [Related]
10. [Expression of ERK5 in multidrug-resistant hepatocellular carcinoma cell line].
Yan F; Wang XM; Pan C
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Mar; 29(3):483-6. PubMed ID: 19304531
[TBL] [Abstract][Full Text] [Related]
11. [Establishment of a multidrug-resistant cell line BEL-7402/5-FU of human hepatocellular carcinoma and its biological characteristics].
Gu W; Zhang YN; Li B; Han J; Cheng BB; Ling CQ
Zhong Xi Yi Jie He Xue Bao; 2006 May; 4(3):265-70. PubMed ID: 16696913
[TBL] [Abstract][Full Text] [Related]
12. The noncytotoxic dose of sorafenib sensitizes Bel-7402/5-FU cells to 5-FU by down-regulating 5-FU-induced Nrf2 expression.
Zhou S; Ye W; Duan X; Zhang M; Wang J
Dig Dis Sci; 2013 Jun; 58(6):1615-26. PubMed ID: 23314856
[TBL] [Abstract][Full Text] [Related]
13. miRNA-195 sensitizes human hepatocellular carcinoma cells to 5-FU by targeting BCL-w.
Yang X; Yin J; Yu J; Xiang Q; Liu Y; Tang S; Liao D; Zhu B; Zu X; Tang H; Lei X
Oncol Rep; 2012 Jan; 27(1):250-7. PubMed ID: 21947305
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of parthenolide and 5-fluorouracil conjugates as potential anticancer agents against drug resistant hepatocellular carcinoma.
Ding Y; Li S; Ge W; Liu Z; Zhang X; Wang M; Chen T; Chen Y; Zhang Q
Eur J Med Chem; 2019 Dec; 183():111706. PubMed ID: 31553932
[TBL] [Abstract][Full Text] [Related]
15. Opsin3 sensitizes hepatocellular carcinoma cells to 5-fluorouracil treatment by regulating the apoptotic pathway.
Jiao J; Hong S; Zhang J; Ma L; Sun Y; Zhang D; Shen B; Zhu C
Cancer Lett; 2012 Jul; 320(1):96-103. PubMed ID: 22313545
[TBL] [Abstract][Full Text] [Related]
16. Proteomic investigation of 5-fluorouracil resistance in a human hepatocellular carcinoma cell line.
Tong SW; Yang YX; Hu HD; An X; Ye F; Hu P; Ren H; Li SL; Zhang DZ
J Cell Biochem; 2012 May; 113(5):1671-80. PubMed ID: 22189913
[TBL] [Abstract][Full Text] [Related]
17. Reversal effect of bufalin on multidrug resistance in human hepatocellular carcinoma BEL-7402/5-FU cells.
Gu W; Liu L; Fang FF; Huang F; Cheng BB; Li B
Oncol Rep; 2014 Jan; 31(1):216-22. PubMed ID: 24173654
[TBL] [Abstract][Full Text] [Related]
18. CDK Inhibition Reverses Acquired 5-Fluorouracil Resistance in Hepatocellular Carcinoma Cells.
Pu Y; Yan D; Tu L; Cheng L; Yu J; Li Z; Zheng X; Wang X
Dis Markers; 2022; 2022():6907057. PubMed ID: 35308136
[TBL] [Abstract][Full Text] [Related]
19. Biological features, gene expression profile, and mechanisms of drug resistance of two- and three-dimensional hepatocellular carcinoma cell cultures.
Mei N; Zhao N; Tian T; Jiao M; Li C
Pharmacol Res Perspect; 2021 Feb; 9(1):e00715. PubMed ID: 33486902
[TBL] [Abstract][Full Text] [Related]
20. Reversal effect of 2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone on multi-drug resistance in resistant human hepatocellular carcinoma cell line BEL-7402/5-FU.
Huang HY; Niu JL; Zhao LM; Lu YH
Phytomedicine; 2011 Sep; 18(12):1086-92. PubMed ID: 21596545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
